InvestorsHub Logo
Post# of 251859
Next 10
Followers 829
Posts 119662
Boards Moderated 16
Alias Born 09/05/2002

Re: ciotera post# 241176

Tuesday, 01/10/2023 10:00:38 AM

Tuesday, January 10, 2023 10:00:38 AM

Post# of 251859
ABBV now_expects Skyrizi/Rinvoq combined_2025_ sales_>=$17.5B—(up_from_prior_guidance_of_>=$15B):

https://finance.yahoo.com/news/abbvie-raises-sales-outlook-two-141249692.html

ABBV also expects peak combined annual sales of these two drugs will exceed $21B in 2027. All this despite the JAK limitation of Rinvoq to the second-line setting in most indications.

Comments?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.